Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells.
Zhu
Hongxia
H
Laboratory of Cell and Molecular Biology, State Key Laboratory of Molecular Oncology, Beijing, China.
Zhang
Guo
G
Wang
Yan
Y
Xu
Ninghong
N
He
Shun
S
Zhang
Wei
W
Chen
Meigui
M
Liu
Mei
M
Quan
Lanping
L
Bai
Jingfeng
J
Xu
Ningzhi
N